Deferred Tax Assets, Net of Valuation Allowance of ESCALON MEDICAL CORP from 30 Jun 2011 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
ESCALON MEDICAL CORP quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 30 Jun 2011 to 30 Jun 2025.
  • ESCALON MEDICAL CORP Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 30 Jun 2025 was $63,681, a 6.8% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

ESCALON MEDICAL CORP Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $63,681 +$4,038 +6.8% 30 Jun 2025 10-K 29 Sep 2025 2025 FY
Q2 2024 $59,643 -$129,370 -68% 30 Jun 2024 10-K 29 Sep 2025 2025 FY
Q2 2023 $189,013 +$171,636 +988% 30 Jun 2023 10-K 30 Sep 2024 2024 FY
Q2 2022 $17,377 -$4,127 -19% 30 Jun 2022 10-K 13 Oct 2023 2023 FY
Q2 2021 $21,504 -$4,127 -16% 30 Jun 2021 10-K 28 Sep 2022 2022 FY
Q2 2020 $25,631 -$131,177 -84% 30 Jun 2020 10-K 27 Sep 2021 2021 FY
Q2 2019 $156,808 -$4,127 -2.6% 30 Jun 2019 10-K 28 Sep 2020 2020 FY
Q2 2018 $160,935 +$68,267 +74% 30 Jun 2018 10-K 27 Sep 2019 2019 FY
Q2 2017 $92,668 -$12,363 -12% 30 Jun 2017 10-K 28 Sep 2018 2018 FY
Q2 2016 $105,031 +$30,418 +41% 30 Jun 2016 10-K 28 Sep 2017 2017 FY
Q2 2015 $74,613 +$74,613 30 Jun 2015 10-K 12 Oct 2016 2016 FY
Q2 2014 $0 $0 30 Jun 2014 10-K 29 Sep 2015 2014 FY
Q2 2013 $0 -$29,945 -100% 30 Jun 2013 10-K 20 Sep 2013 2013 FY
Q2 2012 $29,945 +$4,436 +17% 30 Jun 2012 10-K 20 Sep 2013 2013 FY
Q2 2011 $25,509 30 Jun 2011 10-K 26 Sep 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.